Top Buy
| Security | Buy | Sell | Buy (1M) | Sell (1M) ▲ | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Davita Inc. | 2 | 0 | 0 | 0 | €123.60 | €124.89 | 1.042% |
| Iovance Biotherapeutics Inc. | 19 | 3 | 0 | 0 | €10.70 | €22.78 | 112.853% |
| Ensign Group Inc. | 8 | 0 | 1 | 0 | €110.00 | €116.50 | 5.906% |
| United Therapeutics | 15 | 0 | 0 | 0 | €220.00 | €289.92 | 31.782% |
| Taro Pharmaceutical Industries Ltd | 7 | 0 | 1 | 0 | €39.60 | - | - |
| Merit Medical Systems | 13 | 0 | 2 | 0 | €69.00 | €86.72 | 25.677% |
| Chemed Corp. | 4 | 0 | 0 | 0 | €530.00 | €588.14 | 10.970% |
| Select Medical Holdings | 3 | 0 | 1 | 0 | €25.60 | €36.41 | 42.213% |
| Haemonetics Corp. | 7 | 0 | 1 | 0 | €84.50 | €97.90 | 15.860% |
| Blueprint Medicines Corp | 1 | 0 | 1 | 0 | €87.74 | - | - |
| Integer Hldg | 1 | 0 | 0 | 0 | €101.00 | - | - |
| Amedisys Inc. | 13 | 0 | 1 | 0 | €83.50 | €92.26 | 10.491% |
| Icon plc | 18 | 0 | 6 | 0 | €286.40 | €318.99 | 11.381% |
| QIAGEN NV | 9 | 0 | 0 | 0 | €40.47 | €47.44 | 17.223% |
| LivaNova plc | 7 | 0 | 1 | 0 | €51.00 | €64.66 | 26.782% |
| Icu Medical Inc. | 3 | 0 | 0 | 0 | €87.50 | €124.85 | 42.683% |
| Xencor Inc. | 9 | 1 | 1 | 0 | €18.70 | €31.74 | 69.727% |
| Bio-Techne Corp. | 8 | 0 | 0 | 0 | €60.50 | €75.80 | 25.289% |
| Healthequity Inc. | 1 | 0 | 0 | 0 | €73.50 | €79.00 | 7.483% |
| Charles River Labs Intl | 9 | 0 | 0 | 0 | €213.30 | €247.61 | 16.084% |
| Exelixis Inc. | 15 | 0 | 0 | 0 | €21.94 | €26.01 | 18.534% |
| Neurocrine Bioscience | 23 | 0 | 3 | 0 | €126.55 | €137.63 | 8.759% |
| Tenet Healthcare | 23 | 0 | 2 | 0 | €90.00 | €95.79 | 6.438% |
| Catalent Inc. | 2 | 0 | 0 | 0 | €51.91 | €55.00 | 5.953% |
| Medpace Holdings Inc | 9 | 0 | 3 | 0 | €371.30 | €421.61 | 13.548% |